Polypoidal Choroidal Vasculopathy
Polypoidal choroidal vasculopathy (PCV) is an eye condition characterized by abnormal blood vessel growth in the choroid layer, which can lead to vision loss and other complications.
We are studying the effects of faricimab injections on vision improvement in Caucasian patients with polypoidal choroidal vasculopathy. The trial will also assess the treatment's safety and durability.
Health conditions and diseases that the clinical trial is designed to study and treat.
Polypoidal choroidal vasculopathy (PCV) is an eye condition characterized by abnormal blood vessel growth in the choroid layer, which can lead to vision loss and other complications.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.